Drug Discovery – Page 3

AI Drug Discovery Firm Insitro Lays Off 22% of Workforce Amid Ongoing Biotech Market Turmoil

4 months ago talkbio0Tagged Ambulatory Care Facilities, Aortic Valve Insufficiency, Artificial Intelligence, Biotech Layoffs, biotechnology layoffs, Drug Discovery, Industry, Insitro, Market, Readiness, restructuring, trends qualifier

Insitro, AI drug discovery, biotechnology layoffs, workforce reduction, tumultuous market, industry restructuring, biotech market trends, clinic readiness, cost-cutting, 2025 biotech layoffs

Ono Pharmaceutical and Jorna Therapeutics Partner for AI-Driven RNA Editing Therapies

4 months ago talkbio0Tagged Aortic Valve Insufficiency, Dosage Forms, Drug Discovery, Jorna, RNA

Ono Pharmaceutical, Jorna Therapeutics, AI Drug Discovery, RNA Editing Therapies

PRISM BioLab and Elix Collaborate to Revolutionize AI-Driven Drug Discovery with Peptide Mimetics

4 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Drug Discovery, Efficiency, Elix, mimetics, PepMetics, Peptides, pharmaceutical innovation, PRISM BioLab, Protein-Protein Interaction, small molecule inhibitors

PRISM BioLab , Elix , AI drug discovery , Peptide mimetics , Protein-protein interactions , PepMetics® , Small molecule inhibitors , Drug discovery efficiency , Pharmaceutical innovation

AI-Powered Drug Discovery Breakthrough: Charles River and Valo Health Identify Lupus Candidate

5 months ago talkbio0Tagged Artificial Intelligence, Charles, Drug Discovery, Flagship, Logica, Lupus treatment, Pioneering, Pioneering Medicines, River Laboratories, Valo Health

Charles River Laboratories, Valo Health, Logica platform, AI-driven drug discovery, lupus treatment, Pioneering Medicines, Flagship Pioneering

ReSync Bio, Sapio Sciences adopt Nvidia BioNeMo to supercharge AI drug discovery

5 months ago talkbio0Tagged Aortic Valve Insufficiency, Bio, BioNeMo, Drug Discovery, microservices, NVIDIA 's, Sapio, Sapio Sciences

Drug Discovery, Aortic Valve Insufficiency, Sapio, Sapio Sciences, Bio, NVIDIA ‘s, BioNeMo, microservices

Eli Lilly Partners with Magnet Biomedicine in $1.25B Molecular Glue Deal

6 months ago talkbio0Tagged Biomedicine, Collaboration, Drug Discovery, Eli, Eli Lilly, Magnet, molecular glue, Neoplasms

Eli Lilly, Magnet Biomedicine, molecular glue, drug discovery, oncology, collaboration

Incyte and Genesis Therapeutics Forge $620M AI-Driven Drug Discovery Partnership

6 months ago talkbio0Tagged Artificial Intelligence, Drug Discovery, Gemini of Coiled Bodies, Immunology, Neoplasms, small molecule therapeutics, strategic collaboration

Artificial intelligence, drug discovery, small molecule therapeutics, GEMS platform, oncology, immunology, strategic collaboration

Illumina Announces Layoffs as Incyte Forges AI Partnership for Drug Discovery

6 months ago talkbio0Tagged Aortic Valve Insufficiency, Drug Discovery, FOXD3 gene, Gemini of Coiled Bodies, Illumina, Incyte, Partnership

Illumina, layoffs, Incyte, Genesis Therapeutics, AI partnership, drug discovery, GEMS platform, small molecule therapeutics

Biotech Breakthroughs 2025: Emerging Trends and Technologies Shaping the Industry’s Future

6 months ago talkbio0Tagged Aortic Valve Insufficiency, Cancer Vaccines, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, Drug Discovery, Gene Modification, Investments, personalized therapies, Platform technologies, Precision Medicine, solid-state batteries

CRISPR therapeutics, solid-state batteries, precision medicine, AI in drug discovery, gene editing, cancer vaccines, personalized therapies, biotech investment, platform technologies, clinical trial innovation

AI-Driven Discovery Unveils Novel Antimicrobial Proteins Effective Against Bacterial and Fungal Infections in Mice

6 months ago talkbio0Tagged Artificial Intelligence, Bacterial Infections, Drug Discovery, in vivo studies, Microbicides, Mycoses, Peptides, protein compounds

Artificial intelligence, protein compounds, antimicrobial peptides, drug discovery, bacterial infections, fungal infections, in vivo studies